BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29271400)

  • 1. Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion.
    Wen YA; Zhou BW; Lv DJ; Shu FP; Song XL; Huang B; Wang C; Zhao SC
    Asian J Androl; 2018; 20(2):178-183. PubMed ID: 29271400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value and functional roles of phosphoglycerate mutase 1 in glioma.
    Xu Z; Gong J; Wang C; Wang Y; Song Y; Xu W; Liu Z; Liu Y
    Oncol Rep; 2016 Oct; 36(4):2236-44. PubMed ID: 27572934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathway.
    Liu X; Tan X; Liu P; Wu Y; Qian S; Zhang X
    Oncol Res; 2018 Aug; 26(7):1123-1131. PubMed ID: 29386088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells.
    Shi Z; Wu D; Tang R; Li X; Chen R; Xue S; Zhang C; Sun X
    J Biosci; 2016 Jun; 41(2):229-36. PubMed ID: 27240983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2).
    Gong H; Zhou L; Khelfat L; Qiu G; Wang Y; Mao K; Chen W
    Med Sci Monit; 2019 Apr; 25():3090-3099. PubMed ID: 31026254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGAM1, regulated by miR-3614-5p, functions as an oncogene by activating transforming growth factor-β (TGF-β) signaling in the progression of non-small cell lung carcinoma.
    Li F; Yang H; Kong T; Chen S; Li P; Chen L; Cheng J; Cui G; Zhang G
    Cell Death Dis; 2020 Aug; 11(8):710. PubMed ID: 32855383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion.
    Xin H; Cao Y; Shao ML; Zhang W; Zhang CB; Wang JT; Liang LC; Shao WW; Qi YL; Li Y; Zhang ZY; Yang Z; Sun YH; Zhang PX; Jia LL; Wang WQ
    Int Urol Nephrol; 2018 May; 50(5):861-868. PubMed ID: 29524043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
    Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
    Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
    Guo F; Tian J; Cui M; Fang M; Yang L
    Mol Med Rep; 2015 Jul; 12(1):753-9. PubMed ID: 25738807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity.
    Ohba S; Johannessen TA; Chatla K; Yang X; Pieper RO; Mukherjee J
    Cell Rep; 2020 Apr; 31(2):107518. PubMed ID: 32294440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma.
    Ren F; Wu H; Lei Y; Zhang H; Liu R; Zhao Y; Chen X; Zeng D; Tong A; Chen L; Wei Y; Huang C
    Mol Cancer; 2010 Apr; 9():81. PubMed ID: 20403181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration.
    Obinata D; Takada S; Takayama K; Urano T; Ito A; Ashikari D; Fujiwara K; Yamada Y; Murata T; Kumagai J; Fujimura T; Ikeda K; Horie-Inoue K; Homma Y; Takahashi S; Inoue S
    Eur J Cancer; 2016 Apr; 57():39-49. PubMed ID: 26854828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTSS1 hypermethylation is associated with prostate cancer progression.
    Chen J; Huang L; Zhu Q; Wang Z; Tang Z
    J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New therapeutic schedule for prostatic cancer-3 cells with ET-1 RNAi and Endostar.
    Zhang HJ; Qian WQ; Chen R; Sun ZQ; Song JD; Sheng L
    Asian Pac J Cancer Prev; 2014; 15(23):10079-83. PubMed ID: 25556429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.
    Huang M; Narita S; Tsuchiya N; Ma Z; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Habuchi T
    Carcinogenesis; 2011 Nov; 32(11):1589-96. PubMed ID: 21828059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
    Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
    Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
    Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
    Chen H; Luo Q; Li H
    Tumour Biol; 2017 Mar; 39(3):1010428317695941. PubMed ID: 28345464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.
    Nalla AK; Gorantla B; Gondi CS; Lakka SS; Rao JS
    Cancer Gene Ther; 2010 Sep; 17(9):599-613. PubMed ID: 20448670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells.
    Qu J; Sun W; Zhong J; Lv H; Zhu M; Xu J; Jin N; Xie Z; Tan M; Lin SH; Geng M; Ding J; Huang M
    J Cell Biol; 2017 Feb; 216(2):409-424. PubMed ID: 28122957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.